Name
Jannseni Hambaravi OÜ
Registry code
10625178
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
24.12.1999 (24)
Financial year
01.01-31.12
Capital
160 000.00 €
Activity
68201 - Rental and operating of own or leased real estate 47751 - Retail sale of cosmetic and toilet articles in specialised stores 86231 - Provision of dental treatment
873 982 €
232 006 €
27%
2 310 €
(estimate is approximate)
523 535 €
8
Submitted
No tax arrears
44%
37%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Karmo Vunk 03.12.1978 (45) | 100% - 160 000.00 EEK | Board member | Direct ownership | Founder |
Eva Markson 16.09.1983 (41) | - | Board member | - | |
Kersti Vunk 01.08.1945 (79) | - | - | - | Founder |
2019 27.10.2020 | 2020 29.06.2021 | 2021 29.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 351 764 € | 317 059 € | 383 794 € | 637 597 € | 873 982 € |
Net profit (loss) for the period | 4 862 € | 39 262 € | 33 656 € | 162 844 € | 232 006 € |
Profit Margin | 1% | 12% | 9% | 26% | 27% |
Current Assets | 56 041 € | 93 224 € | 133 843 € | 249 681 € | 481 302 € |
Fixed Assets | 79 659 € | 73 117 € | 66 746 € | 111 188 € | 149 180 € |
Total Assets | 135 700 € | 166 341 € | 200 589 € | 360 869 € | 630 482 € |
Current Liabilities | 57 340 € | 48 719 € | 49 311 € | 52 162 € | 69 286 € |
Non Current Liabilities | - | - | - | - | 37 661 € |
Total Liabilities | - | - | - | - | 106 947 € |
Share Capital | - | - | - | - | - |
Equity | 78 360 € | 117 622 € | 151 278 € | 308 707 € | 523 535 € |
Employees | 8 | 8 | 7 | 7 | 8 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 32 308.72 € | 32 445.11 € | 13 |
2023 Q4 | - | 33 872.45 € | 33 629.02 € | 13 |
2023 Q3 | - | 29 257.72 € | 31 342.58 € | 13 |
2023 Q2 | - | 24 419.97 € | 26 153.2 € | 13 |
2023 Q1 | - | 22 003.89 € | 21 816.17 € | 13 |
2022 Q4 | - | 18 709.85 € | 20 058.42 € | 11 |
2022 Q3 | - | 25 163.77 € | 27 093.5 € | 11 |
2022 Q2 | - | 22 155.69 € | 23 871.04 € | 10 |
2022 Q1 | - | 18 510.99 € | 18 768.12 € | 11 |
2021 Q4 | - | 17 066.13 € | 18 444.67 € | 10 |
2021 Q3 | - | 19 372.75 € | 20 996.43 € | 9 |
2021 Q2 | - | 17 742.76 € | 19 229.25 € | 10 |
2021 Q1 | - | 16 720.12 € | 18 115.83 € | 9 |
2020 Q4 | - | 16 319.82 € | 17 653.93 € | 9 |
2020 Q3 | - | 11 286.83 € | 12 164.73 € | 11 |
2020 Q2 | - | 8 196.16 € | 8 818.4 € | 9 |
2020 Q1 | - | 14 938.95 € | 16 134.8 € | 9 |